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Abstract
Background: The disease burden and associated medical costs of rotavirus infections in inpatient
and outpatient sectors in Taiwan were examined in anticipation of the availability of new rotavirus
vaccines.
Methods: The yearly national case number and medical costs for all for inpatients and outpatients
with acute gastroenteritis (AGE) were extracted from the Bureau of National Health Insurance
database in Taiwan according to ICD-9-CM codes. A retrospective study was also performed using
records of children with AGE seen at three hospitals in Taiwan in 2001 to identify laboratory
confirmed rotavirus infection cases. The annual incidence and related medical costs of AGE due to
rotavirus infection were then estimated.
Results: Children <5 years old comprised 83.6% of inpatient and 62.0% of outpatient pediatric
AGE cases in Taiwan in 2001. Rotavirus was the most common agent detected among AGE patients
in this age group in the three hospitals, and was detected in 32.9% (221/672) of inpatient and 24%
(23/96) of outpatient stool specimens tested for microbial etiologies. An estimated 277,400 to
624,892 cases of rotavirus infections sought medical care in Taiwan in 2001, equaling one in 2 to 5
children <5 years old required medical care due to rotavirus infection. The incidence of
hospitalization due to rotavirus infections was 1,528–1,997/100,000 for children <5 years old. The
total associated medical costs due to rotavirus infection were estimated at US $10–16 millions in
Taiwan in 2001. Although the per-capita medical cost of rotavirus infection was lower in Taiwan
than in the United States or Hong Kong, the personal economic burden was similar among the
three places when normalized for gross national incomes per capita.
Conclusion: Infections caused by rotavirus constitute an important human and economic burden
among young children in Taiwan. A safe and effective vaccine is urgently needed.
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Rotavirus is the leading cause of severe childhood diar-
rhoea in developed and developing countries worldwide.
Virtually all children could be infected before their fifth
birthdays. It is estimated that each year rotavirus infec-
tions are responsible for approximately 2 million hospi-
talizations in children <5 years old worldwide [1,2]. The
World Health Organization estimated that in 2002, over
400,000 deaths due to rotavirus in children <5 years old
were preventable by vaccination [3]. Thus universal child-
hood immunization with rotavirus vaccine is expected to
substantially reduce the mortality and morbidity due to
rotavirus infections in immunocompetent children [4,5].
Rotavirus infections have been reported to occur year-
round in Taiwan [6,7]. Recently, in the first report from
the Asian Rotavirus Surveillance Network (ARSN) by
Bresee et al, rotavirus infection accounted for 28% to 59%
(mean 45%) of children <5 years old admitted to hospi-
tals due to acute diarrhoea in Asia [8]. In a concurrent
study of ARSN, rotavirus was detected in 43% of stool
samples tested for etiology in children <5 years old admit-
ted to 4 sentinel hospitals in Taiwan [9]. However, the
national incidence of rotavirus disease in Taiwan is
unknown, especially in the outpatient sector.
Taiwan implemented a national health insurance pro-
gram in 1995, and by December 2000, over 96 % of its
>22-million population was covered under this universal
healthcare system [10]. The Bureau of National Health
Insurance (BNHI) in Taiwan maintains an extensive data-
base on all inpatient and outpatient visits, including their
medical diagnoses and medical expenditure. In anticipa-
tion of the availability of new rotavirus vaccines, we per-
formed a retrospective study using available data from
three hospitals and the BNHI database to estimate the
burden of rotavirus disease and its associated medical
costs to determine the potential economic impact with




Three hospitals in Taiwan participated in this study. The
National Taiwan University Hospital (NTUH) is a large
2,000-bed medical center located in the highly urbanized
city of Taipei. The Min-Shen Hospital (MSH) is a regional
hospital with 600 beds located in Tao-Yuan City. This is a
satellite city of Taipei and includes more suburban areas.
Both of these hospitals are located in the most densely
populated northern regions of Taiwan. The Buddhist Tzu-
Chi General Hospital (TCH) is a 900-bed hospital in Hua-
Lien City, which is located in the mountainous area of
eastern Taiwan and serves a large rural area. This study was
done independently of the ARSN studies.
We extracted medical and administrative records of all
pediatric patients <5 years old with the principle diagnosis
of acute gastroenteritis (AGE) who were seen in the outpa-
tient department (including emergency rooms), and those
admitted to these three hospitals between March 2001
and February 2002. While estimating the percentage of
AGE attributable to rotavirus infections, patients whose
records appeared both in the outpatients and inpatient
sectors were counted as a single case in the inpatient sec-
tor. Only those whose stool samples were tested for both
rotavirus and bacterial agents were taken into account.
The causative microbes for AGE from patients who had
stool specimens tested for microbial etiology were ana-
lyzed.
Laboratory studies
Stool samples submitted for microbial etiology testing
were tested for rotaviral antigen by monoclonal antibody
incorporated enzyme-linked immunosorbent assay
according to the manufacturer's instructions (Rotaclone,
Meridian Diagnostic, Cincinnati, OH, USA). Bacterial cul-
tures were performed using MacConkey, xylose-lysine-
desoxycholate, Hektoen enteric and thiosulfate-citrate-
bile salts-sucrose agar, and Campylobacter Agar plates
(BBL, Becton Dickinson Microbiology System, Cockeys-
ville, MD, USA) following standard clinical microbiology
protocols.
Data from the Bureau of National Health Insurance 
(BNHI) database
All the identification numbers of individuals were scram-
bled at BNHI before the database was made available for
research purposes through a contract with the National
Health Research Institutes. Because the database inclusive
of all patient visits is tremendously large, we used the sam-
pling database to perform the queries. The sampling data-
base is a systematic sampling of every 500th outpatient
visit and every 20th inpatient visit extracted from the all-
patient records. For 2001, there were over 620,000 outpa-
tient and over 140,000 inpatient records in the sampling
database.
The BNHI database contains registration files, original
claim information and reimbursement data. Medical
diagnoses are coded according to the International Classi-
fication of Diseases, 9th revision, Clinical Modification
(ICD-9-CM). We queried for patients 16 years old and
younger with the following ICD-9-CM diarrhoea-associ-
ated diagnoses codes to analyze the number of AGE cases.
The reimbursements associated with each visit and admis-
sion for these patients were extracted and analyzed. The
codes include: 001 (cholera), 002 (typhoid and paraty-
phoid fever), 003 (salmonellosis), 004 (shigellosis), 005
(other bacterial food poisoning), 006 (amoebiasis), 007
(other protozoan intestinal diseases), 008 (intestinalPage 2 of 8
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tis due to rotavirus), 009 (ill-defined intestinal infec-
tions), 558.9 (other and unspecified noninfectious
gastroenteritis and colitis), and 787.91 (diarrhoea). Cases
with the following codes were excluded in the current
study: 003.2 (localized salmonella infections), 006.2
(amoebic liver abscess), 006.3 (hepatic amoebiasis),
006.4 (amoebic lung abscess), 006.5 (amoebic abscess of
lung and liver), and 006.6 (amoebic skin ulceration).
Estimation of Rotavirus Disease Burden and Medical Costs
Because the majority of rotavirus infections occurs in chil-
dren <5 years old, surveillance of rotavirus infection usu-
ally defines a case of rotavirus diarrhoea as watery
diarrhoea in a child <5 years old whose stool sample
tested positive for rotavirus [11,12]. We adopted this rule
and only cases of AGE in children <5 years old were taken
into account in estimating disease burden or medical cost
of rotavirus infections. The total number of rotavirus AGE
cases was estimated by multiplying the total number of
AGE cases in <5 years old children from the BNHI data-
base and the percentages of laboratory confirmed rotavi-
rus infections. Results from this study as well as those
from the literature were used for this purpose.
Medical care expenses are reimbursed by the BNHI in Tai-
wan. The co-payment data (10% co-payments for hospi-
talized patients and US $1.5–3.0 for outpatients) are
listed in the BNHI database along with reimbursement
data and were included in our medical cost estimation.
Nationwide total medical costs attributable to rotavirus
infections in 2001 were estimated by multiplying the aver-
age BNHI reimbursements per AGE patient with the esti-
mated annual case numbers of rotavirus infections. The
monetary values in New Taiwan dollars (NT $) were con-
verted into United States dollars (US $) based on the aver-
age exchange rate in 2001 (1 US $ = 33.8 NT $). The study
was approved by the Clinical Research Ethics Committee
of the National Taiwan University Hospital.
Results
National Health Insurance System Data
The nationwide case numbers of acute gastroenteritis
(AGE) derived from the BNHI database is shown in Table
1. There were a total of 2,829,740 pediatric patient visits
due to AGE, including 2,750,500 (97.2%) in the ambula-
tory and 79,240 (2.8%) in the inpatient sector in Taiwan
in 2001. The majority of AGE occurred in children <5
years old, with this age group accounting for 62.0%
(1,704,000/2,750,500) and 83.6% (66,260/79,240) of
pediatric outpatients and inpatients with AGE, respec-
tively. However, most of the AGE cases were not coded for
a specific etiologic agent. Instead, the most common
codes reported were "Other and unspecified noninfec-
tious gastroenteritis and colitis" (ICD-9-CM 558.9) and
"Ill-defined intestinal infections" (ICD-9-CM 009). These
two codes together accounted for 95.3%
[(836,500+1,783,500)/2,750,500] of outpatients and
82.0% [(9,500+55,460)/79,240] of inpatients with AGE
related diagnoses.
Enteritis due to rotavirus (ICD-9-CM 00861) was not
reported in any outpatients and was reported only in a
small number (0.4%, 320/79,240) of inpatients. All of the
rotavirus AGE inpatients were in children <5 years old.
Therefore, the prevalence of rotavirus AGE could not be
Table 1: Case numbers of acute gastroenteritis with various ICD-9-CM codes in children in Taiwan, 2001a.
Sectors Age (years old) Case numbers of various acute gastroenteritis associated ICD-9-CMb %d
001 002 003 004 005 007 008c 009 558.9 787.91 Total
Outpatient <5 500 1,000 40,000 500 1,000 500 34,500 540,000 1,085,500 500 1,704,000 62.0
5–16 0 0 20,500 0 5,000 0 24,000 296,500 698,000 2,500 1,046,500 38.0
0–16 500 1,000 60,500 500 6,000 500 58,500 836,500 1,783,500 3,000 2,750,500
Inpatient <5 0 20 4,320 100 40 0 8,180 8,220 45360 20 66,260 83.6
5–16 0 0 440 200 80 0 880 1280 10100 0 12,980 16.4
0–16 0 20 4,760 300 120 0 9060 9500 55460 20 79,240
Total <5 500 1,020 44,320 600 1040 500 42680 548220 1,130,860 520 1,770,260 62.6
5–16 0 0 20,940 200 5080 0 24880 297,780 708100 2500 1,059,480 37.4
0–16 500 1,020 65,260 800 6,120 500 67,560 846,000 1,838,960 3,020 2,829,740
a Extrapolated from the Bureau of National Health Insurance 2001 sampling database in Taiwan (see Methods for details).
b ICD-9-CM: International Classification of Diseases, 9th revision, Clinical Modification. 001, cholera; 002, typhoid and paratyphoid fever; 003, 
salmonellosis [excluding 003.2 (localized Salmonella infections)]; 004, shigellosis; 005, other food poisoning (bacterial); 007, other protozoan 
intestinal diseases; 008, intestinal infections caused by other organisms; 009, ill-defined intestinal infections; 558.9, other and unspecified 
noninfectious gastroenteritis and colitis; 787.91, diarrhoea. There were no cases of 006 (amoebiasis) reported.
c Including 320 cases of ICD-9-CM 008.61, rotavirus.
d Percentage of all 0–16 years old cases.Page 3 of 8
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majority of pediatric AGE cases occurred in <5 years old
children, and because enteritis due to rotavirus was
reported only in this age group in the BNHI database, our
subsequent analysis on rotavirus disease burden focused
on this age group.
Hospital data
During the one-year study period, 5,015 children <5 years
old with AGE were treated at the three participating hos-
pitals. Of these 5,015 patients, 24.3% (1,219) were admit-
ted due to severe diarrhoea and/or vomiting with
dehydration, and were hospitalized for 3 to 5 days (mean
= 4 days). Although laboratory diagnosis for etiology was
performed on only a small proportion of the outpatients
(2.5%, 96/3,796), over half of the hospitalized patients
(55.1%, 672/1,219) were tested for an etiologic agent
including both rotavirus and bacteria (Table 2). In AGE
inpatients, rotavirus accounted for >33% in the 2 hospi-
tals in the north. Although it was detected in lower pro-
portion (18.3%) in the hospital in the east (TCH), it was
still the most common agent detected in that hospital.
Overall, rotavirus was the leading cause of AGE in these
three hospitals, accounting for 24.0% (23/96) of outpa-
tients and 32.9% (221/672) of inpatients tested.
Direct medical costs for AGE
The full medical costs, including BNHI reimbursements
and co-payments for children <5 years old with AGE-asso-
ciated ICD9 codes based on the BNHI data are shown in
Table 3. The BNHI reimbursements for AGE typically
include hospital room charge and nursing fee (40.7%),
pharmacy and treatment-related charges (29.3%), labora-
tory services (14.6%), and physician fee (15.4%) (data
not shown). The values in Table 3 are full medical costs
including BNHI reimbursements, co-payments, and all
governmental subsidies for certain subpopulations. On
average, it cost US $10.8 for each ambulatory patient visit
and US $336.0 for each hospitalization due to AGE.
Although children <5 years old requiring hospitalization
comprised approximately 3.7% (66,260/1,770,260) of
children in this age group with AGE (Table 1), over half
(54.8%, 22,265,691/40,600,883) of the medical expenses
were accrued by these hospitalized patients (Table 3).
Case numbers of rotavirus AGE in children <5 years old
We used a range of 32.9–43% to estimate the total
number of cases of children <5 years old hospitalized with
rotavirus AGE. These numbers were based on results from
our study of three hospitals, which showed that 32.9% of
<5 years old children hospitalized due to AGE were attrib-
utable to rotavirus infection, as well as the study of Chen
et al [9], which found 43% of the same age group of AGE
patients admitted to 4 sentinel hospitals in Taiwan were
due to rotavirus infection. For outpatients, we used a
range of 15–35% based on the report of Glass et al [13]
since the 24.0% of our three hospital data fall within this
range.
The annual case number for rotavirus AGE would there-
fore be 255,600–596,400 (1,704,000 × 15–35%) for out-
patients and 21,800–28,492 (66,260 × 32.9–43%) for
inpatients, for a total of 277,400–624,892 episodes of
rotavirus infections in children <5 years old needing med-
ical care in 2001 in Taiwan (Table 4). Since the popula-
tion of children <5 years old was 1,426,759 in Taiwan in
2001 [14], the incidence of rotavirus infection in children
this age group would be 19.4–43.8% (277,400–624,892/
1,426,759). In other words, an estimated 1 out of every 2
to 5 children <5 years old in Taiwan could have rotavirus
Table 2: Number of cases and distribution of etiological diagnoses in children <5 years old with acute gastroenteritis (AGE) seen at 
three hospitals in Taiwan in 2001a.
Cases of AGE in: NTUH MSH TCH Total of 3 hospitals
Outpatients 1,274 1,679 843 3,796
Tested for etiology, Nb 67 12 17 96
Positive for rotavirus, N (%)c 18 (26.9) 2 (16.7) 3 (17.6) 23 (24.0)
Positive for Salmonella, N (%) 9 (13.4) 2 (16.7) 4 (23.5) 15 (15.6)
Positive for Shigella, N (%) 0 0 0 0
Positive for Campylobacter, N (%) 1 (1.5) NTd NT -
Inpatients 408 378 433 1,219
Tested for etiology, N 287 292 93 672
Positive for rotavirus, N (%) 106 (36.9) 98 (33.6) 17 (18.3) 221 (32.9)
Positive for Salmonella, N (%) 34 (11.8) 26 (8.9) 8 (8.6) 68 (10.1)
Positive for Shigella, N (%) 0 2 (0.7) 12 (12.9) 14 (2.1)
Positive for Campylobacter, N (%) 1 (0.3) NT NT -
a NTUH, National Taiwan University Hospital; MSH, Min-Shen Hospital; TCH, Buddhist Tzu-Chi General Hospital.
b Number of AGE cases tested for both rotavirus and bacterial agents.
c Percentage of those tested.
d NT, Not tested.Page 4 of 8
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pitalization rate for rotavirus infections would be 1,528–
1,997/100,000 (21,800–28,492/1,426759) in children of
this age group.
The estimated medical expenses due to rotavirus infec-
tions in children <5 years old were extrapolated using the
average cost per patient multiplied by the number of esti-
mated rotavirus cases (Table 4). Based on these calcula-
tions, an estimated total medical expenditure of US
$10.1–16.0 million, including US $2.8–6.4 million for
outpatients and US $7.3–9.6 million for inpatients was
spent in 2001 for treating rotavirus infections in young
children in Taiwan.
Comparison of medical cost for rotavirus hospitalization in 
Taiwan, Hong Kong, and USA
We also compared the annual direct medical costs for hos-
pitalizations due to rotavirus infections in Taiwan (US
$7–10 million) with data available from USA (US $217
million in 1996 dollar) [15] and Hong Kong (US $4 mil-
lion in 2001–2003) for children <5 years old [16]. After
normalization with population and gross national
income (GNI) per capita for 2001 [14,17], the economic
burden could be compared among different countries.
Although the direct medical cost for rotavirus infections
per capita was lower in Taiwan (US $0.31–0.44) than in
Hong Kong (US $0.59) or USA (US $0.76), the personal
economic burden indexes were similar among Taiwan
(1.92–2.72), Hong Kong (2.28), and USA (2.19) when
normalized for GNI per capita (Table 5).
Discussion
This is the first analysis of the prevalence and medical
costs of childhood rotavirus AGE for both inpatients and
outpatients in Taiwan. This analysis confirmed rotavirus
as a leading cause of AGE in children <5 years old who
sought medical care in Taiwan. Nearly one third (32.9%)
of hospitalized AGE cases were caused by rotavirus. This
finding is comparable to data reported from previous
studies in other countries, which ranged from 25% to
50%. Rotavirus accounted for 30–50% of diarrhoeal hos-
pitalization in <5 years old children in England [18], 27%
in diarrhoeal consultations in El Salvador [19], and 42 %
of diarrhoeal admission in Argentina [20]. In New York,
rotavirus infection was reported in >30% of diarrhoea
cases in children younger than 5 years of age [21].
In a separate study of 4 hospitals in Taiwan, Chen et al
found that 43% of AGE cases in <5 years old children hos-
pitalized were attributable to rotavirus [9]. There are sev-
eral explanations for the difference in our data (32.9%)
and that of Chen et al. In two of the hospitals we studied,
over 33% of the young children with AGE hospitalized
were attributable to rotavirus. The lower proportion
(18%) of the patients with rotavirus AGE at the third hos-
Table 4: The direct medical cost for rotavirus acute gastroenteritis (AGE) in <5 years old children in Taiwan, 2001
Sector Medical cost (in US $) per case Total AGE Estimated rotavirus AGE
Case no. Total medical cost Case no. Total medical cost
Outpatient 10.8 1,704,000 18,395,192 255,600–596,400a 2,760,480–6,441,120
Inpatient 336.0 66,260 22,265,691 21,800–28,492b 7,324,800–9,573,312
Total - 1,770,260 40,660,883 277,400–624,892 10,085,280–16,014,432
a The range of 15–35% was used for estimating outpatient rotavirus AGE case number based on Glass et al., (Reference [13]).
b For estimation of hospitalized rotavirus AGE case number, 32.9% was used as the lower end based on the three hospital data in the present study 
and 43% was used as the upper end based on study of Chen et al (Reference [9]).
Table 3: National health insurance reimbursements and co-pays for children <5 years old with various acute gastroenteritis ICD-9-CM 
codes in Taiwan in 2001.
Sectors Medical costs (in US $) for various acute gastroenteritis associated ICD-9-CMa
001 002 003 004 005 007 008 009 558.9 787.91 Total Averageb
Outpatient 5,237 8,905 394,497 7,012 10,828 5,636 350,178 5,706,479 11,900,784 5,636 18,395,192 10.8
Inpatient 0 3,353 1,986,493 30,337 8,383 0 2,800,989 2,413,857 15,018,609 3,668 22,265,691 336.0
Total 5,237 12,259 2,380,991 37,349 19,211 5,636 3,151,167 8,120,336 26,919,393 9,304 40,660,883 -
a ICD-9-CM: International Classification of Diseases, 9th revision, Clinical Modification. 002, typhoid and paratyphoid fever; 003, salmonellosis 
[excluding 003.2 (localized Salmonella infections)]; 004, shigellosis; 005, other food poisoning (bacterial); 007, other protozoan intestinal diseases; 
008, intestinal infections caused by other organisms; 0086, enteritis due to specified virus; 00861, rotavirus; 009, ill-defined intestinal infections; 
558.9, other and unspecified noninfectious gastroenteritis and colitis; 787.91, diarrhoea. There were no cases with the ICD-9-CM of 006 
(amoebiasis) in this age group.
b Total medical costs divided by total case numbers (1,704,000 for outpatients and 66,260 for inpatients) (See Table 1 for details).Page 5 of 8
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where the hospital is located is the least populated moun-
tainous area and one where bacterial dysentery remains
an important infectious disease. Most other parts of Tai-
wan, including where the other two hospitals we studies
are located, are highly urbanized and more densely popu-
lated. The lower rate of rotavirus infections in the hospital
in the east might have underrepresented rotavirus in that
region thus lowering our estimation for the whole coun-
try. Another possible explanation is that not all children
with AGE in the three hospitals we studied had stool spec-
imens tested for microbial etiology. Different testing prac-
tices might have led to an underestimation of the
incidence of rotavirus infection. We therefore used the
43% reported by Chen et al [9] as the upper range and our
32.9% as the lower range to estimate the rotavirus disease
burden in children hospitalized due to AGE in Taiwan.
The true incidence of rotavirus infections in the outpatient
sectors is unknown because pediatricians tend not to per-
form rotavirus testing in typical cases of mild watery diar-
rhoea. This is especially true for the outpatient sector in
Taiwan as evidenced by the fact that less than 3% of the
outpatients with AGE were tested for etiology in the three
hospitals we studied. We feel that the use of 15–35%
range reported by Glass et al [13] provides a good estimate
for outpatient rotavirus disease burden in Taiwan since
rotavirus was detected in 24% of the outpatients tested in
these three hospitals.
Our results indicated that the disease burden of rotavirus
infections could be higher in Taiwan than many other
countries. An estimated one out of every 2 to 5 children
younger than 5 years of age sought medical care due to
rotavirus infections in Taiwan in 2001. The risks of chil-
dren in the same age group requiring an outpatient visit
due to rotavirus infection were estimated to be 1 out of 7
in the United States and 1 out of 5 globally [13]. Our esti-
mation of the annual incidence of hospitalization due to
rotavirus infections of 1,528–1,997/100,000 in the <5
years old children in Taiwan is also higher than many
countries, including Finland (610/100,000 in 1985–
1995) [22], and Australia (750–870/100,000 in 1991–
1996) [23][24]. We do not have any biological explana-
tion for the high hospitalization rate due to rotavirus
infections in Taiwan. An earlier report revealed the inci-
dence of rotavirus disease is similar in children in differ-
ent countries, regardless of the degree of development [1].
The high hospitalization rate in Taiwan might be due to
the easy accessibility to and relatively low cost of health
care. With the support of the National Health Insurance
system, the medical costs are affordable to most of the
population. Children with moderate to severe diarrhoea
with early signs of dehydration are frequently admitted to
the hospitals in Taiwan.
Of noteworthy is that although valuable information can
be obtained from the extensive database maintained by
the Bureau of National Health Insurance (BNHI) in Tai-
wan, very few AGE cases were coded as enteritis due to
rotavirus (ICD9-00861) in the BNHI database. Although
children with gastroenteritis who have no pathogen iso-
lated should be correctly coded as ICD 009 (ill-defined
intestinal infections), the BNHI data showed that ICD
code 558.9 (other and unspecified noninfectious gastro-
enteritis and colitis) was often used instead. Earlier studies
by Nelson et al on rotavirus disease burden also incorpo-
rated codes 558.9 and 787.91 (diarrhoea) into their anal-
ysis of disease burden of rotavirus infections [11]. There
are several explanations for the non-specific ICD coding
in Taiwan. Rotavirus AGE is clinically indistinguishable
from AGE caused by other pathogens. Physicians in Tai-
wan also do not have the incentives to look for specific eti-
ologic agents because insurance reimbursement is not
higher for more specific diagnostic ICD coding. Stool test-
ing is seldom done by practitioners or in local hospitals.
Thus laboratory diagnosis and specific ICD coding should
be encouraged to increase our understanding of the roles
different etiologic agents play in causing diseases in Tai-
wan's patients.
Table 5: Normalized medical costs for rotavirus acute gastroenteritis (AGE) hospitalizations in Taiwan, Hong Kong, and the United 
States (USA)
Taiwan Hong Kongb USAc
Direct medical cost for rotavirus AGE (in US $) 7–10 mil 4 mil 217 mil
Populationa 22.9 mil 6.8 mil 285.3 mil
Medical cost per capita (A) 0.31–0.44 0.59 0.76
Gross National Incomes (GNI) per capitaa (B) 16,170 26,060 34,800
Normalized economic burden index due to rotavirus AGE (A/B × 105) 1.92–2.72 2.28 2.19
a Population and GNI per capita in 2001 was used [References 14 and 17].
b The Hong Kong study was based on hospital data of 2001–2003 [reference 16].
c  Because the direct medical costs estimate for USA was reported in 1996 dollars [reference 15], and we used the population and GNI data from 
2001, the upper range of their sensitivity for cost estimate was used (4,346 US $ per hospitalization × 50,000 hospitalizations)Page 6 of 8
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of rotavirus infection was lower in Taiwan than that of the
United States and Hong Kong, the personal economic
burden was similar among the three places when normal-
ized for gross national incomes per capita. Therefore, peo-
ple in countries with different degrees of development
have similar economic burdens from rotavirus infections.
Other than the direct medical costs, one must also take
into account associated indirect costs including an out of
pocket registration fee for each outpatient visit (US $1.5–
3.0), extra diapers and laundry, special diets, transporta-
tion, lost of income from work, and additional child care
needs resulting from children having rotavirus infections.
Thus the social and economical burden of rotavirus infec-
tions could be in actuality much higher than the above-
mentioned figures.
Conclusion
Rotavirus remains a leading etiologic agent for acute gas-
troenteritis in children <5 years old in Taiwan. Even
though mortality from rotavirus infection is no longer a
significant problem due to easy access to medical care in
Taiwan, the morbidity due to rotavirus is still very high.
An estimated one out of every 2 to 5 children in the <5
years old group required medical care due to rotavirus
infection in Taiwan in 2001 with an estimated annual
medical expenditure of US $10–16 million. It is hoped
that preventive measures, including introduction of safe
and effective rotavirus vaccines, would decrease the
human and economic burdens of rotavirus disease in Tai-
wan.
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